Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2013, Article ID 703925, 4 pages
Case Report

Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

1Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY 12208, USA
2The Endocrine Group, LLP, Albany, NY 12206, USA

Received 5 April 2013; Accepted 28 July 2013

Academic Editors: A. T. Soliman and A. Spalice

Copyright © 2013 Sara J. Micale et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Elisabeth Streckel, Christina Braun-Reichhart, Nadja Herbach, Maik Dahlhoff, Barbara Kessler, Andreas Blutke, Andrea Baehr, Nicole Uebel, Matthias Eddicks, Mathias Ritzmann, Stefan Krebs, Burkhard Goeke, Helmut Blum, Ruediger Wanke, Eckhard Wolf, and Simone Renner, “Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition,” Journal Of Translational Medicine, vol. 13, 2015. View at Publisher · View at Google Scholar
  • Simone Renner, Andreas Blutke, Elisabeth Streckel, Rüdiger Wanke, and Eckhard Wolf, “Incretin actions and consequences of incretin-based therapies: lessons from complementary animal models,” The Journal of Pathology, vol. 238, no. 2, pp. 345–358, 2015. View at Publisher · View at Google Scholar
  • Fatemeh Akhlaghi, Kelly L Matson, Amir Hooshang Mohammadpour, Meghan Kelly, and Asieh Karimani, “Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus.,” Clinical pharmacokinetics, vol. 56, no. 6, pp. 561–571, 2017. View at Publisher · View at Google Scholar